Published March 2026 — Updated Regularly

Suboxone Lawsuit Settlement Estimates 2026: What to Expect

Last updated: March 2026

People considering the Suboxone dental injury lawsuit want a straight answer: what can I actually expect to receive? That's fair. This page gives realistic Suboxone lawsuit settlement estimates based on what we know about MDL 3092, the factors that drive case value, and how comparable pharmaceutical mass torts have resolved.

Important: No global settlement has been announced as of March 2026. These numbers are projections — not guaranteed amounts. No attorney can promise a specific recovery.

That said, understanding the realistic range helps you decide whether to file and what documentation to prioritize.

Where MDL 3092 Stands in 2026

MDL 3092 — the Suboxone dental injury multidistrict litigation — is centralized in the Northern District of Ohio before Judge David Ruiz. As of early 2026:

• More than 7,000 cases have been filed — and new cases are still being added weekly
• Both sides are deep in discovery (exchanging documents, taking depositions, developing expert witnesses)
• Bellwether case selection is underway — a small group of representative cases that will go to trial first
• No global settlement has been announced
• Bellwether trials are anticipated in 2026–2027

The litigation is at a stage that mass tort practitioners recognize as building toward settlement — but has not yet reached the inflection point where a deal is announced. That inflection point typically arrives when bellwether trials are imminent or early verdicts have clarified case values.

Why No Settlement Has Been Reached Yet

People sometimes wonder why thousands of lawsuits exist without any money changing hands. This is normal for large pharmaceutical mass torts. The timeline is typically measured in years, not months. Here is why MDL 3092 has not yet settled:

The Science Is Still Being Litigated

Indivior's defense is expected to challenge the scientific claim that Suboxone film specifically caused dental damage in individual plaintiffs — arguing that other factors (prior drug use, oral hygiene, diet, genetics) were the real cause. Resolving this requires extensive expert testimony, Daubert hearings, and potentially early trial outcomes. Courts will not settle without a clear picture of causation.

The Case Count Is Still Growing

Defendants negotiating global settlements want a fixed population of claimants. When thousands of new cases are still being filed monthly, Indivior cannot accurately calculate its total liability. Settlement negotiations typically accelerate when the incoming wave of new cases slows — usually as statute of limitations deadlines pass.

Bellwether Trials Have Not Produced Verdicts Yet

Bellwether trials serve a pricing function in mass tort litigation. A plaintiff verdict of $500,000 sends a very different signal than a defense verdict. Until bellwether cases go to trial, both sides are working with projections rather than confirmed data points. The closer those trials get, the more pressure there is to settle rather than risk an unfavorable outcome.

Indivior's Financial Position

Indivior (formerly part of Reckitt Benckiser, now independent) has faced previous legal and financial challenges, including a major U.S. Department of Justice settlement in 2019 related to Suboxone marketing practices. The company's financial capacity to fund a massive settlement — and the timing of any deal — is part of the negotiation context.

What Factors Determine Your Suboxone Settlement Amount?

In mass tort settlements, plaintiffs are typically grouped into tiers based on their individual injuries. Higher tiers receive larger payments. The main factors that determine which tier you fall into are:

1. Severity of Dental Damage

This is the primary driver of settlement value. The more teeth you lost, the more treatment you needed, and the more extensively your oral health was damaged, the higher your projected settlement amount. Cases are typically grouped as:

• Severe: Multiple extractions, full dentures, dental implants, or major reconstructive procedures (e.g., full-arch restoration)
• Moderate: Several cavities requiring restoration, a few extractions, crown work on multiple teeth
• Mild to moderate: Documented enamel erosion, early cavities, sensitivity — but without major structural tooth loss

2. Documented Treatment Costs

Dental bills are powerful evidence. The economic damages portion of your claim is anchored in actual and projected treatment costs. A single dental implant can cost $3,000–$6,000. Full-arch implant-supported restoration can run $20,000–$50,000 or more per arch. Multiple extractions, crowns, root canals, and future monitoring costs add up rapidly. Plaintiffs with documented bills and future treatment estimates have stronger cases than those who did not seek dental care.

3. Duration and Frequency of Film Use

The longer you used the film and at what dosage, the greater your cumulative acid exposure — and the stronger the causal link between the film and your dental damage. A patient who used Suboxone film twice daily for five years has a much stronger causal argument than a six-month user. Prescription records documenting the full duration of film use are essential.

4. Prior Dental Health (Before-and-After Evidence)

Cases are significantly stronger when dental records from before starting Suboxone film show good or reasonable dental health — and records from after show clear deterioration. This before-and-after pattern directly refutes the defense argument that dental problems existed before the film. Old X-rays, prior dental treatment records, and dentist notes from the pre-film period are valuable evidence.

5. Age and Future Impact

Younger patients face more total years of dental consequences — more dental treatments needed, more quality-of-life impact over a longer lifetime. Age is considered in calculating damages for pain and suffering and ongoing costs. A 28-year-old who lost six teeth faces a different lifetime burden than a 60-year-old with the same injury.

6. Non-Economic Damages

Beyond the dollar cost of dental treatment, claimants can seek compensation for pain and suffering, emotional distress, and loss of enjoyment of life. For patients who avoided social situations, experienced chronic pain, or suffered from the emotional toll of losing their teeth — particularly patients in recovery who were already navigating significant life challenges — these non-economic damages can be substantial.

7. Documentation Quality

Claims with thorough, complete documentation — dental records, X-rays, treatment estimates, prescription histories, pharmacy fill records — are evaluated more favorably than claims with gaps. Poor documentation does not necessarily disqualify a claim, but it limits the attorney's ability to establish every element of damages.

Projected Suboxone Lawsuit Settlement Ranges

Based on analysis of MDL 3092's development stage and injury severity tiers — and drawing on comparable mass tort settlements — here are rough projected settlement ranges:

These are gross estimates before attorney fees. Standard contingency fees in mass tort cases typically range from 33% to 40% of your recovery. Always confirm your attorney's fee structure before signing a retainer.

These figures could shift substantially based on bellwether trial outcomes. If early trials produce large plaintiff verdicts, values across the MDL would increase. If defendants win early trials, values would decrease. Monitoring what happens in bellwether trials is the single most important factor to watch.

How Do These Numbers Compare to Other Mass Tort Settlements?

Suboxone dental cases are somewhat unique in mass tort history — dental injury as the primary harm is less common than cancer, neurological injury, or death. For context, here is how the projected values compare to other major pharmaceutical mass torts:

Roundup (Monsanto / Bayer) — Non-Hodgkin's Lymphoma

Bayer agreed to pay $10.9 billion to resolve approximately 125,000 Roundup lawsuits. That works out to an average of roughly $87,000 per resolved case before fees — though individual verdicts before settlement reached $2 billion. Roundup cases involved cancer, a life-threatening condition with far greater severity than dental injury. Per-case values were higher, but so was the severity of harm.

Talcum Powder (Johnson & Johnson) — Ovarian Cancer

J&J faced individual jury verdicts ranging from $75 million to $4.69 billion and eventually sought a bankruptcy resolution for talc claims. Individual case values for ovarian cancer — a serious, often fatal condition — were far higher than dental injury cases. However, the litigation path (bellwethers → pressure → global settlement) mirrors what is developing in MDL 3092.

Paraquat — Parkinson's Disease

Paraquat litigation (linking the herbicide to Parkinson's disease) remains ongoing in MDL 3004. Projected individual case values for Parkinson's — a devastating, progressive neurological disease — are estimated at $100,000–$300,000+ per case for moderate-to-severe presentations. Again, higher severity = higher case values.

What This Comparison Tells Us

Suboxone dental cases involve real, significant harm — but dental injury is generally valued lower than cancer, Parkinson's, or other life-threatening conditions. The projected ranges of $10,000–$150,000 are consistent with this comparative framework. They also reflect the reality that Indivior's financial capacity is not unlimited — a defendant with less capital produces lower per-case settlement values even when liability is clear.

What About Going to Trial Instead?

Every plaintiff has the right to reject any settlement offer and take their case to trial. Individual trials can produce dramatically higher verdicts than settlement averages — particularly if the jury is sympathetic and finds that Indivior acted with recklessness or deliberate concealment.

However, trials also carry significant risk:

• Defendants can win. A defense verdict means you receive nothing.
• Trials take years longer than settlements.
• Litigation costs are higher, potentially reducing net recovery even in a plaintiff victory.
• Appeals can delay payment for additional years after a verdict.

Most mass tort plaintiffs — and most attorneys — choose a reasonable settlement over the uncertainty of trial. This is especially true once a global settlement process is in place, since the settlement amounts reflect negotiated value based on thousands of similar cases.

When Will Suboxone Lawsuit Settlements Be Paid?

There is no way to predict exactly when the first global settlement will be announced. But the pattern in large pharmaceutical MDLs is fairly consistent:

1. Discovery and expert witness development (currently underway)
2. Daubert hearings (ruling on expert testimony admissibility)
3. Bellwether trial preparation and scheduling
4. Settlement pressure intensifies as first trials approach
5. Global settlement announced — often before the first bellwether verdict
6. Claims administration process (can take 1–3 additional years to distribute funds)

If MDL 3092 follows this pattern — with bellwether trials scheduled for 2026–2027 — global settlement discussions could intensify in late 2026 or 2027. Actual payments to claimants could follow over the subsequent years.

Why Filing Now Matters for Your Settlement Position

People sometimes think: "I'll wait until a settlement is announced and file then." This is a costly mistake. Here is why filing now matters:

• Statutes of limitations: Every state has a filing deadline. If you miss it, your claim is barred — permanently. These deadlines are running right now.
• Settlement cutoffs: When a global settlement is announced, there is typically a claims period for registered plaintiffs. People who have not already filed may be excluded from the settlement or receive lower tier treatment.
• Record availability: Old dental records and prescription records are easier to gather now than they will be in three years. Records get destroyed, practices close, and memories fade.
• No upfront cost: Filing costs you nothing. Mass tort attorneys take these cases on pure contingency.

Start your free case evaluation today →

Sources

• FDA Drug Safety Communication. "FDA warns about dental problems with buprenorphine medicines dissolved in the mouth." January 12, 2022. fda.gov
• In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Sublingual Film Products Liability Litigation, MDL No. 3092 (N.D. Ohio). Docket available via PACER.
• Bayer AG. Settlement press release regarding Roundup litigation resolution. June 2020.
• U.S. Department of Justice. "Indivior Solutions Pleads Guilty to Felony Charge Relating to Suboxone Film Marketing." July 2019.
• In re: Paraquat Products Liability Litigation, MDL 3004 (S.D. Ill.). Current docket status.